TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Yesterday

NL

Article

gbudwell published an article 4:23 AM

4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist

Little known NPS Pharmaceuticals has fallen hard of late, along with other biotechs. Yet there are four compelling reasons why you should keep tabs on this stock.

NL

Article

gbudwell published an article 2:15 AM

How Are Orphan Drugmakers Faring in the Great Biotech Downturn?

Orphan drugmakers led the biotech rally upward. Is it now leading it downward?

Wed Apr 16

NL

Article

gbudwell published an article 11:38 AM

2 Reasons Why Merck & Co. Is Crushing the Dow

Merck is up double digits this year and outperforming the major indexes. Why?

NL

Article

gbudwell published an article 4:29 AM

1 of These 3 Cratering Biotechs is a Buy

Biotech stocks have been performing poorly in general this year. However, some biotechs have been having a truly terrible year. Here's a look at the three worst-performing biotechs and their respective chances at making a comeback.

Sun Apr 13

NL

Article

gbudwell published an article 10:01 PM

Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?

Last week saw a widespread downturn among biotech stocks. Regeneron Pharmaceuticals, however, was able to move modestly higher. Why?

NL

Article

gbudwell published an article 7:11 AM

3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics

Last week's three worst performing biotech stocks.

Sat Apr 12

NL

Article

gbudwell published an article 11:38 PM

Are Biotechs Bad Medicine for the S&P 500?

Are biotechs to blame for the recent downturn in the S&P 500?

Fri Apr 11

NL

Article

gbudwell published an article 8:30 AM

Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences

Today's top stories in health care and biotech.

NL

Article

gbudwell published an article 4:34 AM

3 Health Care Stocks Bucking the S&P Downtrend

Health care stocks have been falling hard of late. Have they been dragging broader indices down with them?

Thu Apr 10

NL

Article

gbudwell published an article 7:10 AM

Can This Drug Be a Game Changer for Eli Lilly?

Eli Lilly's experimental breast cancer drug is reporting strong results in an early-stage trial. Here is what you need to know going forward.

NL

Article

gbudwell published an article 7:08 AM

Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Inc.

Morning movers in biotech and health care.

Wed Apr 9

NL

Article

gbudwell published an article 10:10 AM

More Trouble Looming for Amarin Corporation?

Teva announced yesterday that it's launching a generic version of GlaxoSmithKline's Lovaza. Will this launch hurt Amarin's competing product?

NL

Article

gbudwell published an article 4:35 AM

Why Enanta Pharmaceuticals, Inc. Should Be on Your Watchlist

Enanta Pharmaceuticals and its collaborator AbbVie are inching closer to a regulatory filing for their hepatitis C drug. Here is what you need to know heading into this event.

Mon Apr 7

NL

Article

gbudwell published an article 10:43 AM

Is Now the Time to Invest in Agios Pharmaceuticals, Inc?

Agios Pharmaceuticals reported surprisingly strong results for an early stage blood cancer drug candidate today. Should you dig deeper into this story?

Sun Apr 6

NL

Article

gbudwell published an article 2:50 PM

5 Stocks Forging the Future of Breast Cancer Care

Pharmacotherapies for breast cancer are undergoing an innovation boom. Which biotechs offer the most compelling investment opportunities in this space?

Fri Apr 4

NL

Article

gbudwell published an article 8:20 AM

Morning Movers in Biotech: Celgene Corporation, Mylan, Inc. and Exelixis, Inc.

Today's top stories in health care and biotech.

Thu Apr 3

NL

Article

gbudwell published an article 8:18 AM

Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.

Today's top stories in health care and biotech.

Wed Apr 2

NL

Article

gbudwell published an article 8:14 PM

2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals

Two clinical-stage cancer companies could provide market-beating returns for risk-tolerant investors.

NL

Article

gbudwell published an article 3:06 AM

What’s Next for MannKind Corp.?

MannKind's inhaled insulin product Afrezza was recommended for approval by an FDA panel yesterday, causing shares to double in after-hours trading. Should you hold or take profits?

Mon Mar 31

NL

Article

gbudwell published an article 11:12 PM

5 Biotechs With Prostate Cancer Treatments Worth Watching

Prostate cancer is now the second leading cause of cancer-specific deaths among men in the United States. Here are five biotechs aiming to meet this challenge with a diversity of promising new therapies.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75542
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick GILD (+7.59)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts